These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28025101)

  • 61. 7-Epitaxol induces apoptosis in cisplatin-resistant head and neck squamous cell carcinoma via suppression of AKT and MAPK signalling.
    Yang HJ; Velmurugan BK; Chen MK; Lin CC; Lo YS; Chuang YC; Ho HY; Hsieh MJ; Ko JL
    J Cell Mol Med; 2022 Dec; 26(23):5807-5819. PubMed ID: 36308422
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeted Therapies in HPV-positive and -negative HNSCC - Alteration of EGFR and VEGFR-2 Expression In Vitro.
    Kramer B; Hock C; Birk R; Sauter A; Stuck BA; Hörmann K; Schultz JD; Aderhold C
    Anticancer Res; 2016 Jun; 36(6):2799-807. PubMed ID: 27272791
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.
    Becker EM; Alonso-Alija C; Apeler H; Gerzer R; Minuth T; Pleiss U; Schmidt P; Schramm M; Schröder H; Schroeder W; Steinke W; Straub A; Stasch JP
    BMC Pharmacol; 2001; 1():13. PubMed ID: 11801189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
    Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
    Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel CREB5/TOP1MT axis confers cisplatin resistance through inhibiting mitochondrial apoptosis in head and neck squamous cell carcinoma.
    Tong T; Qin X; Jiang Y; Guo H; Wang X; Li Y; Xie F; Lu H; Zhai P; Ma H; Zhang J
    BMC Med; 2022 Jul; 20(1):231. PubMed ID: 35773668
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines.
    Manthey KC; Glanzer JG; Dimitrova DD; Oakley GG
    Head Neck; 2010 May; 32(5):636-45. PubMed ID: 19787780
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects.
    Hu H; Li B; Wang J; Tan Y; Xu M; Xu W; Lu H
    Biomed Pharmacother; 2023 Jul; 163():114778. PubMed ID: 37137185
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases.
    Sandner P; Becker-Pelster EM; Stasch JP
    Nitric Oxide; 2018 Jul; 77():88-95. PubMed ID: 29738821
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Downregulation of IGF1R Expression Inhibits Growth and Enhances Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cells In Vitro.
    Khalil A; Jameson MJ
    Horm Cancer; 2019 Feb; 10(1):11-23. PubMed ID: 30350263
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
    Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
    Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.
    Gelbard A; Garnett CT; Abrams SI; Patel V; Gutkind JS; Palena C; Tsang KY; Schlom J; Hodge JW
    Clin Cancer Res; 2006 Mar; 12(6):1897-905. PubMed ID: 16551875
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of DNA translesion synthesis polymerase η in head and neck squamous cell cancer predicts resistance to gemcitabine and cisplatin-based chemotherapy.
    Zhou W; Chen YW; Liu X; Chu P; Loria S; Wang Y; Yen Y; Chou KM
    PLoS One; 2013; 8(12):e83978. PubMed ID: 24376779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
    Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Research progress of squamous cell carcinoma of head and neck EGFR targeted therapy resistance mechanisms].
    Song Q; Li X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):184-90. PubMed ID: 25989677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma.
    Liu CW; Hua KT; Li KC; Kao HF; Hong RL; Ko JY; Hsiao M; Kuo ML; Tan CT
    Mol Cancer Ther; 2017 Jul; 16(7):1421-1434. PubMed ID: 28265008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma.
    Gao J; Zhao S; Halstensen TS
    Oncol Rep; 2016 Jun; 35(6):3265-74. PubMed ID: 27108527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells.
    Roy S; Roy S; Anuja K; Thakur S; Akhter Y; Padhi S; Banerjee B
    Arch Oral Biol; 2021 Feb; 122():104981. PubMed ID: 33302041
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
    Ryumon S; Okui T; Kunisada Y; Kishimoto K; Shimo T; Hasegawa K; Ibaragi S; Akiyama K; Thu Ha NT; Monsur Hassan NM; Sasaki A
    Oncol Rep; 2019 Dec; 42(6):2611-2621. PubMed ID: 31638244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.